DOI: 10.1055/s-00000071

Seminars in Neurology


Bar-Or A, Grove R, Austin D , et al.
The MIRROR study: a randomized double-blind, placebo-controlled, parallel-group, dose-ranging study to investigate the safety and MRI efficacy of subcutaneous ofatumumab in subjects with relapsing-remitting multiple sclerosis.
Paper presented at: 66th American Academy of Neurology Annual Meeting; April 26–May 3, 2014; Philadelphia, PA

Download Bibliographical Data

Search in: